Stock Market Trending News - StockTitan

Please enter your login and password
Forgot password?
Don’t have an account? Sign Up!
Please enter your email address
To create a free account, please fill out the form below.
Already have an account? Login
Welcome to our list of the most viewed stock market news.
Updated every minute, this automated list is generated based on real-time analytics to bring you the news articles that are receiving the most attention right now.
Whether you’re an investor, a trader, or simply curious about the financial markets, you’ll find this list to be a valuable resource for keeping tabs on market trends and company updates.
Navigate through the top news and stay informed with the most current insights in the stock market world.
Innoviz Technologies (Nasdaq: INVZ), a Tier-1 supplier of automotive LiDAR sensors and perception software, has announced new technological developments to be showcased at CES 2025. The company is demonstrating its perception software running on the NVIDIA DRIVE AGX Orin platform, featuring software-driven capabilities for autonomous driving applications.
The collaboration with NVIDIA marks a significant advancement in AI-enabled perception systems. Innoviz’s software, optimized for the NVIDIA DRIVE Orin platform, enables real-time processing and advanced environmental understanding, offering enhanced object detection, classification, and tracking capabilities for autonomous driving and ADAS systems.
The company will conduct live demonstrations at CES 2025 (West Hall, booth #4216), showcasing the integration of their LiDAR technology with NVIDIA’s platform. The solution aims to support automakers in scaling from L2+ ADAS to fully autonomous vehicles.
XTI Aerospace (NASDAQ: XTIA) has announced a strategic update for 2025, including a 1-for-250 share consolidation of its common stock. The consolidation, effective January 10, 2025, aims to regain Nasdaq compliance and strengthen the company’s position for long-term growth.
Following improvements to its balance sheet and cap table structure in 2024, XTI plans to raise capital and pursue strategic acquisitions. The company is focusing on expanding its leadership in the VTOL industry, particularly with its flagship product, the TriFan 600, following the FAA’s formalization of the powered-lift category.
The share consolidation will maintain shareholders’ ownership percentages, with fractional shares rounded up. Outstanding stock options and warrants will be adjusted accordingly, while the number of authorized shares and par value remain unchanged. Computershare will manage the exchange process for shareholders of record.
UniFirst (NYSE: UNF) has confirmed its Board of Directors’ unanimous rejection of an unsolicited acquisition proposal from Cintas received in November and December 2024. The proposal offered to acquire all outstanding common and Class B shares at $275.00 per share.
After careful review with independent advisors, the Board determined the proposal was not in the best interests of UniFirst, its shareholders, and stakeholders. The decision was based on the offer price, execution and business risks, feedback from major shareholders, and the company’s future growth prospects. The Board and management team expressed confidence in their current strategy and commitment to creating shareholder value.
J.P. Morgan Securities and Paul Hastings LLP are serving as financial and legal advisors, respectively.
Hoth Therapeutics (NASDAQ: HOTH) has announced promising interim results from its Phase 2a clinical trial of HT-001, a treatment targeting skin toxicities associated with Epidermal Growth Factor Receptor Inhibitors (EGFRi) in cancer patients. The CLEER-001 trial demonstrated 100% success rate in achieving the primary efficacy endpoint, with all patients showing significant skin toxicity improvement within six weeks.
Key outcomes include 66% of patients reporting reduced pain and itching scores, and notably, all patients maintained their full EGFRi cancer treatment dosage without reductions. The trial utilizes the proprietary Acneiform Rash Investigator Global Assessment Scale (ARIGA) for precise measurement of improvements. Importantly, no treatment-related adverse effects were reported, confirming HT-001’s safety profile.
Rail Vision (RVSN) has signed a binding Memorandum of Understanding (MOU) with Sujan Ventures, a division of the Sujan Group, to introduce its advanced railway safety systems to the Indian market. The agreement targets India’s national railway system, which operates approximately 15,000 locomotives.
Under the MOU terms, Sujan Ventures will lead local efforts and have exclusive distribution rights in India. The collaboration will begin with a trial of Rail Vision’s systems at customer facilities. Upon approval, the parties will proceed with a definitive agreement. Sujan Ventures will make an initial upfront payment and additional milestone-based payments.
The partnership aims to position Rail Vision’s technologies for inclusion in future tenders requiring thousands of locomotives to be equipped with advanced accident avoidance systems, particularly for adverse weather conditions. The collaboration also aligns with India’s ‘Make in India’ initiatives, ensuring locally-sourced safety systems meet global standards.
Enovix (ENVX) has secured a significant pre-paid purchase order from a leading Silicon Valley-based AI and immersive technology company for custom battery solutions designed for Mixed Reality (MR) wearables. The batteries will power next-generation head-worn devices, including smart glasses and augmented reality products.
Initial shipments are scheduled for mid-2025, with production taking place at the company’s Fab2 facility in Penang, Malaysia. The agreement adds substantial contracted backlog to Fab2’s production pipeline. Enovix’s 3D silicon anode technology was chosen for its high energy density, compact form factor, and performance capabilities essential for MR applications.
The company plans to launch EX-1M this year and EX-2M in 2026, demonstrating its commitment to advancing battery technology for next-generation devices.
Quantum Computing Inc. (QUBT) has secured its third and fourth purchase orders for its thin film lithium niobate (TFLN) photonic chip foundry. The orders come from a European technical university focusing on telecommunications applications and a Canadian photonic integrated circuit design house – their first non-research customer.
The company completed partial delivery of its first foundry customer’s order in December 2024 to an Asian client. QCi’s US-based semiconductor foundry in Tempe, Arizona, is scheduled for full-scale production in Q1 2025, focusing on high-performance photonic chips and TFLN devices.
The Canadian PIC design company’s order includes custom TFLN PIC chip development with expected delivery in Q2 2025, and priority access to a multi-project wafer run planned for H2 2025. QCi plans to showcase its foundry services at SPIE Photonics West 2025 in San Francisco.
Counterpart Health, a subsidiary of Clover Health (NASDAQ: CLOV), has successfully deployed its Counterpart Assistant technology at Duke Connected Care (DCC). The AI-powered physician enablement platform is now being used by primary care physicians across DCC’s network of non-employed physicians.
The cloud-based AI platform integrates with existing electronic health record systems to provide real-time, actionable insights for improved chronic disease management and patient outcomes. DCC, part of Duke University Health System, is a physician-led accountable care organization supporting 2,200 providers and 200,000 patients.
The implementation aims to unify and optimize performance across DCC’s network of community practices, particularly benefiting small rural practices that may not have access to advanced EHR systems. The technology, previously known as Clover Assistant, has demonstrated positive impacts on Clinical Quality, Medication Adherence, and management of Diabetes and Chronic Kidney Disease.
Serve Robotics (Nasdaq: SERV), an autonomous sidewalk delivery company, has announced a registered direct offering of 4,210,525 shares of common stock. The offering is expected to generate $80.0 million in gross proceeds before deducting placement agent fees and other expenses. The transaction is anticipated to close on January 7, 2025, subject to customary closing conditions.
The company plans to use the net proceeds for general corporate purposes, including working capital. Northland Capital Markets is serving as the exclusive placement agent. The offering is being conducted under an effective shelf registration statement on Form S-3, which was declared effective by the SEC on October 3, 2024.
© 2020-2025 StockTitan.net